Find your next paid study

An Open-label, Multi-center Protocol for Patients Who Have Completed a Previous Novartis Sponsored Secukinumab Study and Are Judged by the Investigator to Benefit From Continued Secukinumab Treatment

The purpose of this study is to assess long term safety in participants who have completed a Novartis trial with secukinumab, have been judged by the investiga…